LATIN AMERICA HEALTHCARE PARTNER
Bridging Global
Innovation with
Local Impact
Andes Therapeutics connects world-class pharmaceutical and biotech manufacturers with trusted commercial partners across Latin America — ensuring essential, affordable, and high-impact therapies reach the patients and health systems that need them most.
WHO WE ARE
A Regional Partner
Built for LATAM
Andes Therapeutics is a dedicated healthcare bridge between global pharmaceutical and biotech innovators and the dynamic markets of Latin America. Headquartered in Lima, Peru, we combine deep regional expertise with a rigorous understanding of local regulatory environments, procurement systems, and commercial landscapes.
We don't just open doors — we build durable partnerships that drive sustainable market access, ensure compliant product registration, and ultimately deliver meaningful therapies to patients across the region.
WHAT WE DO
Six Core
Capabilities
From first market-entry strategy to ongoing portfolio management — we cover the full commercial lifecycle in LATAM.
Strategic Market Entry
End-to-end guidance for global manufacturers entering LATAM markets — regulatory pathways, commercial infrastructure setup, and partner selection tailored to each country's requirements.
Distribution & Licensing
We connect proven manufacturers with reliable local distributors and licensing partners across Rx, specialty care, biosimilars, generics, and OTC categories throughout the region.
Tender & Institutional Access
Deep expertise in navigating complex public procurement ecosystems, developing winning pricing strategies, and executing supply chains for government and institutional health buyers.
Portfolio Development
Data-driven identification of unmet healthcare needs across LATAM markets, bringing differentiated products to health systems through regional intelligence and commercial analysis.
Regulatory Affairs
Comprehensive regulatory support including strategy design, dossier preparation, and direct coordination with national regulatory authorities across all target markets in Latin America.
Legal and Intellectual
Property (IP) Services
We support pharmaceutical, biotechnology, and healthcare companies in protecting their innovations and navigating complex regulatory and commercial legal frameworks across Latin America.
WHAT WE CARRY
A Broad Portfolio,
A Unified Mission
We partner with leading international manufacturers to introduce, register, and commercialize high-quality therapies across our markets. Our portfolio spans consumer health, prescription medicines, biologics, biosimilars, and advanced specialty treatments.
Oncology & Hematology
Solid tumors and hematologic malignancies, including complex hospital-setting therapies.
Immunology & Autoimmune
Targeted therapies for chronic inflammatory and immune-mediated disorders.
Cardiovascular & Metabolic
Medicines for hypertension, dyslipidemia, and diabetes — high-prevalence conditions in emerging markets.
Central Nervous System
Treatments for neurological and psychiatric disorders across both outpatient and hospital settings.
Consumer Health & OTC
Vitamins, supplements, pain management, respiratory, and dermatological products via pharmacy and retail channels.
Urology, Pain & Anti-infectives
Essential therapies supporting comprehensive outpatient and hospital care needs.
Through our integrated capabilities, we don't just distribute — we build the full ecosystem for your product to thrive.
Biosimilars & Biologics
Navigating the complex regulatory and market-access landscape for biologic therapies across multiple LATAM jurisdictions simultaneously.
Specialty Care Focus
Dedicated infrastructure for high-value specialty therapies that require specialized distribution, patient support, and HCP engagement programs.
Generics & Accessible Medicines
Broad generics portfolio ensuring essential medicines are affordable and reliably available to patients and institutions across the region.
Advanced Therapies Pipeline
Positioning our partners for the next wave of innovation — cell therapies, gene therapies, and precision medicine in emerging LATAM markets.

